RT Journal Article SR Electronic T1 The potential contribution of vaccination uptake to occupational differences in risk of SARS-CoV-2: Analysis of the ONS COVID-19 Infection Survey JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2023.03.24.23287700 DO 10.1101/2023.03.24.23287700 A1 Jack Wilkinson A1 Evangelia Demou A1 Mark Cherrie A1 Rhiannon Edge A1 Matthew Gittins A1 S Vittal Katikireddi A1 Theocharis Kromydas A1 William Mueller A1 Neil Pearce A1 Martie van Tongeren A1 Sarah Rhodes YR 2023 UL http://medrxiv.org/content/early/2023/03/26/2023.03.24.23287700.abstract AB Objectives To assess variation in vaccination uptake across occupational groups as a potential explanation for variation in risk of SARS-CoV-2 infection.Design We analysed data from the UK Office of National Statistics COVID-19 Infection Survey linked to vaccination data from the National Immunisation Management System in England from December 1st 2020 to 11th May 2022. We analysed vaccination uptake and SARS-CoV-2 infection risk by occupational group and assessed whether adjustment for vaccination reduced the variation in risk between occupational groups.Results Estimated rates of triple-vaccination were high across all occupational groups (80% or above), but were lowest for food processing (80%), personal care (82%), hospitality (83%), manual occupations (84%), and retail (85%). High rates were observed for individuals working in health (95% for office-based, 92% for those in patient-facing roles) and education (91%) and office-based workers not included in other categories (90%). The impact of adjusting for vaccination when estimating relative risks of infection was generally modest (ratio of hazard ratios reduced from 1.38 to 1.32), but was consistent with the hypothesis that low vaccination rates contribute to elevated risk in some groups. Conversely, estimated relative risk for some occupational groups, such as people working in education, remained high despite high vaccine coverage.Conclusions Variation in vaccination coverage might account for a modest proportion of occupational differences in infection risk. Vaccination rates were uniformly very high in this cohort, which may suggest that the participants are not representative of the general population. Accordingly, these results should be considered tentative pending the accumulation of additional evidence.Competing Interest StatementSVK was co-chair of the Scottish Government's Expert Reference Group on Ethnicity and COVID-19 and a member of the UK Scientific Advisory Group on Emergencies subgroup on ethnicityFunding StatementThis work was supported with funding from the ONS (ONS Ref PU-22-0205). MG, NP, MvT, JW, SR acknowledge funding through the National Core Study 'PROTECT' programme, managed by the Health and Safety Executive on behalf of HM Government. TK, ED and SVK acknowledge funding from the Medical Research Council (MRC; MC_UU_00022/2) and the Chief Scientist Office (CSO; SPHSU17). SVK also acknowledges funding from a NRS Senior Clinical Fellowship (SCAF/15/02).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The COVID-19 Infection Survey received ethical approval from the South-Central Berkshire B Research Ethics Committee (20/SC/0195). All participants provided informed consent. For use of this data for this project statistics authority self-assessment classified the study as low risk. This assessment was approved by the Office for National Statistics (ONS) Research Accreditation Panel.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesONS CIS data can be accessed only by researchers who are Office of National Statistics (ONS) accredited researchers. Researchers can apply for accreditation through the Research Accreditation Service. Access is through the Secure Research Service (SRS) and approved on a project basis. For further details see: https://www.ons.gov.uk/aboutus/whatwedo/statistics/requestingstatistics/approvedresearcherscheme